Table of Contents Author Guidelines Submit a Manuscript
Journal of Thyroid Research
Volume 2011 (2011), Article ID 306487, 4 pages
http://dx.doi.org/10.4061/2011/306487
Clinical Study

Occurrence of Type 1 Diabetes in Graves' Disease Patients Who Are Positive for Antiglutamic Acid Decarboxylase Antibodies: An 8-Year Followup Study

1Division of Endocrinology & Metabolism, Department of Internal Medicine, Showa University Fujigaoka Hospital, 1-30 Fujigaoka, Aoba-ku, Yokohama, Kanagawa 227-8501, Japan
2Department of Internal Medicine, Tokyo Denryoku Hospital, 9-2 Shinanomachi, Shinjuku-ku, Tokyo 160-0016, Japan
3Ito Hospital, 4-3-6 Jingumae, Shibuya-ku, Tokyo 150-8308, Japan

Received 31 August 2010; Revised 27 November 2010; Accepted 7 December 2010

Academic Editor: Gary L. Francis

Copyright © 2011 Matsuo Taniyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Zhang, R. Gianani, M. Nakayama et al., “Type 1 diabetes: chronic progressive autoimmune disease,” Novartis Foundation Symposium, vol. 292, pp. 85–94, 2008. View at Google Scholar · View at Scopus
  2. R. D. G. Leslie, M. A. Atkinson, and A. L. Notkins, “Autoantigens IA-2 and GAD in type I (insulin-dependent) diabetes,” Diabetologia, vol. 42, no. 1, pp. 3–14, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Barker, “Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 4, pp. 1210–1217, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. L. C. Groop, G. F. Bottazzo, and D. Doniach, “Islet cell antibodies identify latent type I diabetes in patients aged 35–75 years at diagnosis,” Diabetes, vol. 35, no. 2, pp. 237–241, 1986. View at Google Scholar · View at Scopus
  5. T. Tuomi, L. C. Groop, P. Z. Zimmet, M. J. Rowley, W. Knowles, and I. R. Mackay, “Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease,” Diabetes, vol. 42, no. 2, pp. 359–362, 1993. View at Google Scholar · View at Scopus
  6. R. Kahn, “Report of the expert committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 20, no. 7, pp. 1183–1197, 1997. View at Google Scholar · View at Scopus
  7. A. C. Tarn, J. M. Thomas, B. M. Dean et al., “Predicting insulin-dependent diabetes,” The Lancet, vol. 1, no. 8590, pp. 845–850, 1988. View at Google Scholar · View at Scopus
  8. G. J. Bruining, J. L. Molenaar, D. E. Grobbee et al., “Ten-year follow-up study of islet-cell antibodies and childhood diabetes mellitus,” The Lancet, vol. 1, no. 8647, pp. 1100–1103, 1989. View at Google Scholar · View at Scopus
  9. J. M. Barker, S. H. Goehrig, K. Barriga et al., “Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up,” Diabetes Care, vol. 27, no. 6, pp. 1399–1404, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Sosenko, J. P. Krischer, J. P. Palmer et al., “A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1,” Diabetes Care, vol. 31, no. 3, pp. 528–533, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. LaGasse, M. S. Brantley, N. J. Leech et al., “Successful prospective prediction of type 1 diabetes in the general population,” Diabetes Care, vol. 33, pp. 1206–1212, 2010. View at Google Scholar
  12. P. J. Bingley, “Clinical applications of diabetes antibody testing,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 1, pp. 25–33, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. G. S. Eisenbarth and P. A. Gottlieb, “Medical progress: autoimmune polyendocrine syndromes,” The New England Journal of Medicine, vol. 350, no. 20, pp. 2068–2079, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Kawasaki, H. Takino, M. Yano et al., “Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease,” Diabetes, vol. 43, no. 1, pp. 80–86, 1994. View at Google Scholar · View at Scopus
  15. E. Kawasaki, N. Abiru, M. Yano et al., “Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies,” Journal of Autoimmunity, vol. 8, no. 5, pp. 633–643, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Hallengren, A. Falorni, M. Landin-Olsson, A. Lernmark, K. I. Papadopoulos, and G. Sundkvist, “Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment,” Journal of Internal Medicine, vol. 239, no. 1, pp. 63–68, 1996. View at Google Scholar · View at Scopus
  17. D. Maugendre, F. Verite, I. Guilhem, B. Genetet, H. Allannic, and M. Delamaire, “Anti-pancreatic autoimmunity and Graves' disease: study of a cohort of 600 Caucasian patients,” European Journal of Endocrinology, vol. 137, no. 5, pp. 503–510, 1997. View at Google Scholar · View at Scopus
  18. A. Kasuga, T. Maruyama, Y. Ozawa et al., “Antibody to the Mr 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese,” Journal of Autoimmunity, vol. 9, no. 1, pp. 105–111, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Ozawa, A. Kasuga, T. Maruyama et al., “Antibodies to the 37,000-Mr tryptic fragment of islet antigen were detected in Japanese insulin-dependent diabetes mellitus patients,” Endocrine Journal, vol. 43, no. 6, pp. 615–620, 1996. View at Google Scholar · View at Scopus
  20. A. Huber, F. Menconi, S. Corathers, E. M. Jacobson, and Y. Tomer, “Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms,” Endocrine Reviews, vol. 29, no. 6, pp. 697–725, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Yanagawa, Y. Hidaka, V. Guimaraes, M. Soliman, and L. J. DeGroot, “CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population,” Journal of Clinical Endocrinology and Metabolism, vol. 80, no. 1, pp. 41–45, 1995. View at Google Scholar · View at Scopus
  22. H. Ueda, J. M. M. Howson, L. Esposito et al., “Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease,” Nature, vol. 423, no. 6939, pp. 506–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Yanagawa, M. Taniyama, S. Enomoto et al., “CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese,” Thyroid, vol. 7, no. 6, pp. 843–846, 1997. View at Google Scholar · View at Scopus
  24. N. Bottini, L. Musumeci, A. Alonso et al., “A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes,” Nature Genetics, vol. 36, no. 4, pp. 337–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Taniyama, T. Maruyama, T. Tozaki, Y. Nakano, and Y. Ban, “Association of PTPN22 haplotypes with type 1 diabetes in the Japanese population,” Human Immunology, vol. 71, pp. 795–798, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. R. Velaga, V. Wilson, C. E. Jennings et al., “The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 11, pp. 5862–5865, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Ban, T. Tozaki, M. Taniyama et al., “Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the japanese population,” Thyroid, vol. 20, no. 8, pp. 893–899, 2010. View at Publisher · View at Google Scholar
  28. I. Kusaka, S. Nagasaka, K. Fujibayashi et al., “Immunologically-related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement,” Endocrine Journal, vol. 46, no. 6, pp. 747–754, 1999. View at Google Scholar · View at Scopus
  29. M. Knip, S. Korhonen, P. Kulmala et al., “Prediction of type 1 diabetes in the general population,” Diabetes Care, vol. 33, no. 6, pp. 1206–1212, 2010. View at Publisher · View at Google Scholar